001053164 001__ 1053164
001053164 005__ 20260223122512.0
001053164 0247_ $$2doi$$a10.1016/j.parkreldis.2026.108178
001053164 0247_ $$2ISSN$$a1353-8020
001053164 0247_ $$2ISSN$$a1873-5126
001053164 0247_ $$2datacite_doi$$a10.34734/FZJ-2026-01496
001053164 0247_ $$2pmid$$a41512492
001053164 0247_ $$2WOS$$aWOS:001665926300001
001053164 037__ $$aFZJ-2026-01496
001053164 082__ $$a610
001053164 1001_ $$0P:(DE-Juel1)194632$$aRöttgen, Sinah$$b0$$eFirst author
001053164 245__ $$aCompartment-specific correlation of pathological α-synuclein in prodromal Parkinson's disease
001053164 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2026
001053164 3367_ $$2DRIVER$$aarticle
001053164 3367_ $$2DataCite$$aOutput Types/Journal article
001053164 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1769764678_17018
001053164 3367_ $$2BibTeX$$aARTICLE
001053164 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001053164 3367_ $$00$$2EndNote$$aJournal Article
001053164 500__ $$aFunding Else Kroner-Fresenius-Stiftung (grant number 2019_EKES.02); Koln Fortune Program, Faculty of Medicine, University of Cologne; Ilselore-Luckow-Stiftung.
001053164 520__ $$antroductionNeuronal α-synuclein dyshomeostasis and aggregation are essential features of early Parkinson's disease, as seen in isolated REM sleep behavior disorder (iRBD). The link between these pathologies across body compartments remains unclear. Our aim was to assess correlations between α-synuclein aggregates in stool and urine with α-synuclein content in neuronally derived L1CAM extracellular vesicles (L1EVs) from serum in iRBD.MethodsWe conducted a cross-sectional study, analyzing concurrent biobank samples from 46 individuals with iRBD to quantify α-synuclein aggregates in stool and urine with surface-based fluorescence intensity distribution analysis (sFIDA) and α-synuclein content in L1EVs using electrochemiluminescence.ResultsCorrected for age and sex, α-synuclein concentrations in L1EVs significantly correlated with stool aggregate concentration. No significant correlation was observed between α-synuclein concentration in L1EVs and urine, nor between urine and stool aggregates.ConclusionThe correlation of serum and stool α-synuclein suggests shared or linked pathology across these compartments, whereas the urinary compartment may be pathophysiologically distinct in prodromal Parkinson's Disease.
001053164 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001053164 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001053164 7001_ $$0P:(DE-Juel1)179044$$aSommerauer, Michael$$b1$$eCorresponding author$$ufzj
001053164 7001_ $$00009-0007-4933-4238$$aYan, Shijun$$b2
001053164 7001_ $$0P:(DE-HGF)0$$aHungerland, Carolin$$b3
001053164 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon Rudolf$$b4$$ufzj
001053164 7001_ $$00000-0001-5858-7762$$aOphey, Anja$$b5
001053164 7001_ $$00000-0003-1149-8054$$aBarbe, Michael T.$$b6
001053164 7001_ $$aMüller, Laura$$b7
001053164 7001_ $$0P:(DE-Juel1)177986$$aTamgüney, Gültekin$$b8
001053164 7001_ $$00000-0002-9252-5933$$aTofaris, George K.$$b9
001053164 773__ $$0PERI:(DE-600)2027635-7$$a10.1016/j.parkreldis.2026.108178$$gVol. 144, p. 108178 -$$p108178 -$$tParkinsonism & related disorders$$v144$$x1353-8020$$y2026
001053164 8564_ $$uhttps://juser.fz-juelich.de/record/1053164/files/PDF.pdf$$yOpenAccess
001053164 909CO $$ooai:juser.fz-juelich.de:1053164$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001053164 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)194632$$aForschungszentrum Jülich$$b0$$kFZJ
001053164 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)179044$$aForschungszentrum Jülich$$b1$$kFZJ
001053164 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b4$$kFZJ
001053164 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177986$$aForschungszentrum Jülich$$b8$$kFZJ
001053164 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001053164 9141_ $$y2026
001053164 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001053164 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
001053164 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001053164 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
001053164 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-11-12
001053164 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-11-12
001053164 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-11-12
001053164 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-11-12
001053164 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-11-12
001053164 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPARKINSONISM RELAT D : 2022$$d2025-11-12
001053164 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-11-12
001053164 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-11-12
001053164 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-11-12
001053164 920__ $$lyes
001053164 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
001053164 9201_ $$0I:(DE-Juel1)IBI-7-20200312$$kIBI-7$$lStrukturbiochemie$$x1
001053164 980__ $$ajournal
001053164 980__ $$aVDB
001053164 980__ $$aUNRESTRICTED
001053164 980__ $$aI:(DE-Juel1)INM-3-20090406
001053164 980__ $$aI:(DE-Juel1)IBI-7-20200312
001053164 9801_ $$aFullTexts